General Information of Drug Formulation (ID: F09897)

Formulation Name
Hydroxyurea 300 mg capsule
Company
E.R. Squibb & Sons
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Hydroxyurea DMOQVU9 Chronic myelogenous leukaemia 2A20.0 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Beta-D-lactose E00099 6134 Diluent; Dry powder inhaler carrier; Lyophilization aid
Citric acid monohydrate E00271 22230 Acidulant; Antioxidant; Buffering agent; Complexing agent; Flavoring agent
D&C red no. 28 E00491 6097185 Colorant
D&C red no. 33 E00261 19116 Colorant
FD&C blue no. 1 E00263 19700 Colorant
Magnesium stearate E00208 11177 lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent